Castle Financial & Retirement Planning Associates’s GSK GSK Stock Holding History

Castle Financial & Retirement Planning Associates’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$16K	Buy	+280	New	+$14.6K	0.05%	74

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Castle Financial & Retirement Planning Associates's GSK Position: Q4 2021 in Review

Castle Financial & Retirement Planning Associates opened a new position in GSK (GSK) in Q4 2021: 280 shares worth $16K. The stake represents 0.05% of the portfolio and ranks #74 among its holdings.

919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

Castle Financial & Retirement Planning Associates held 280 shares of GSK worth $16K as of Q4 2021.
GSK was a new Castle Financial & Retirement Planning Associates position in Q4 2021.
GSK made up 0.05% of Castle Financial & Retirement Planning Associates's portfolio in Q4 2021, its #74 holding.
919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Castle Financial & Retirement Planning Associates's 13F filing for Q4 2021, filed 14 Feb 2022.